JAZZ vs. BCRX
Compare and contrast key facts about Jazz Pharmaceuticals plc (JAZZ) and BioCryst Pharmaceuticals, Inc. (BCRX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: JAZZ or BCRX.
Correlation
The correlation between JAZZ and BCRX is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
JAZZ vs. BCRX - Performance Comparison
Loading data...
Key characteristics
JAZZ:
-0.04
BCRX:
1.05
JAZZ:
0.13
BCRX:
2.36
JAZZ:
1.02
BCRX:
1.28
JAZZ:
-0.05
BCRX:
1.11
JAZZ:
-0.26
BCRX:
7.70
JAZZ:
10.31%
BCRX:
11.83%
JAZZ:
34.46%
BCRX:
55.73%
JAZZ:
-96.90%
BCRX:
-97.74%
JAZZ:
-43.54%
BCRX:
-69.09%
Fundamentals
JAZZ:
$6.72B
BCRX:
$2.14B
JAZZ:
$7.56
BCRX:
-$0.26
JAZZ:
3.89
BCRX:
-0.28
JAZZ:
1.65
BCRX:
4.26
JAZZ:
1.57
BCRX:
56.59
JAZZ:
$4.06B
BCRX:
$503.49M
JAZZ:
$3.45B
BCRX:
$487.50M
JAZZ:
$1.28B
BCRX:
$40.77M
Returns By Period
In the year-to-date period, JAZZ achieves a -11.51% return, which is significantly lower than BCRX's 36.17% return. Over the past 10 years, JAZZ has underperformed BCRX with an annualized return of -4.95%, while BCRX has yielded a comparatively higher -1.06% annualized return.
JAZZ
-11.51%
6.03%
-10.42%
-0.01%
-1.20%
-4.95%
BCRX
36.17%
38.38%
45.66%
63.06%
15.80%
-1.06%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
JAZZ vs. BCRX — Risk-Adjusted Performance Rank
JAZZ
BCRX
JAZZ vs. BCRX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Jazz Pharmaceuticals plc (JAZZ) and BioCryst Pharmaceuticals, Inc. (BCRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
JAZZ vs. BCRX - Dividend Comparison
Neither JAZZ nor BCRX has paid dividends to shareholders.
Drawdowns
JAZZ vs. BCRX - Drawdown Comparison
The maximum JAZZ drawdown since its inception was -96.90%, roughly equal to the maximum BCRX drawdown of -97.74%. Use the drawdown chart below to compare losses from any high point for JAZZ and BCRX. For additional features, visit the drawdowns tool.
Loading data...
Volatility
JAZZ vs. BCRX - Volatility Comparison
The current volatility for Jazz Pharmaceuticals plc (JAZZ) is 15.98%, while BioCryst Pharmaceuticals, Inc. (BCRX) has a volatility of 24.22%. This indicates that JAZZ experiences smaller price fluctuations and is considered to be less risky than BCRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
JAZZ vs. BCRX - Financials Comparison
This section allows you to compare key financial metrics between Jazz Pharmaceuticals plc and BioCryst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
JAZZ vs. BCRX - Profitability Comparison
JAZZ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Jazz Pharmaceuticals plc reported a gross profit of 793.22M and revenue of 897.84M. Therefore, the gross margin over that period was 88.4%.
BCRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, BioCryst Pharmaceuticals, Inc. reported a gross profit of 140.97M and revenue of 145.53M. Therefore, the gross margin over that period was 96.9%.
JAZZ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Jazz Pharmaceuticals plc reported an operating income of -55.89M and revenue of 897.84M, resulting in an operating margin of -6.2%.
BCRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, BioCryst Pharmaceuticals, Inc. reported an operating income of 21.23M and revenue of 145.53M, resulting in an operating margin of 14.6%.
JAZZ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Jazz Pharmaceuticals plc reported a net income of -92.54M and revenue of 897.84M, resulting in a net margin of -10.3%.
BCRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, BioCryst Pharmaceuticals, Inc. reported a net income of 32.00K and revenue of 145.53M, resulting in a net margin of 0.0%.